MedPath

Randomized, double-blind, split-side, comparison study of moisturizer containing MAS064D and 1% hydrocortisone in the treatment of infantile seborrheic dermatitis

Phase 4
Completed
Conditions
children less than 1 year oldseborrheic dermatitis
MAS064D&#44
1% hydrocortisone&#44
efficacy&#44
seborrheic dermatitis
Registration Number
TCTR20160819001
Lead Sponsor
A.Menarini (Thailand) Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

children, less than 1 year old, with seborrheic dermatitis who did not receive any treatment within 2 weeks

Exclusion Criteria

children with infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical improvement 28 days Scoring system
Secondary Outcome Measures
NameTimeMethod
flare free period 28 days scoring system,safety of products 28 days clinical evaluation
© Copyright 2025. All Rights Reserved by MedPath